Wiysonge Charles Shey, Waggie Zainab, Hawkridge Anthony, Schoub Barry, Madhi Shabir Ahmed, Rees Helen, Hussey Gregory
Vaccines for Africa Initiative, Institute of Infectious Disease and Molecular Medicine, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa; Centre for Evidence-based Health Care, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa.
Vaccines for Africa Initiative, Institute of Infectious Disease and Molecular Medicine, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa; Division of Medical Microbiology, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa.
Pan Afr Med J. 2016 Feb 29;23:53. doi: 10.11604/pamj.2016.23.53.9097. eCollection 2016.
One means of improving healthcare workers' knowledge of and attitudes to vaccines is through running vaccine conferences which are accessible, affordable, and relevant to their everyday work. Various vaccinology conferences are held each year worldwide. These meetings focus heavily on basic science with much discussion about new developments in vaccines, and relatively little coverage of policy, advocacy, and communication issues. A negligible proportion of delegates at these conferences come from Africa, home to almost 40% of the global burden of vaccine-preventable diseases. To the best of our knowledge, no major vaccinology conference has ever been held on the African continent apart from World Health Organization (WHO) meetings. The content of the first International African Vaccinology Conference was planned to be different; to focus on the science, with a major part of discussions being on clinical, programmatic, policy, and advocacy issues. The conference was held in Cape Town, South Africa, from 8 to 11 November 2012. The theme of the conference was "Advocating for efforts to protect African children, families, and communities from the threat of infectious diseases". There were more than 550 registered participants from 55 countries (including 37 African countries). There were nine pre-conference workshops, ten plenary sessions, and 150 oral and poster presentations. The conference discussed the challenges to universal immunisation in Africa as well as the promotion of dialogue and communication on immunisation among all stakeholders. There was general acknowledgment that giant strides have been made in Africa since the global launch of the Expanded Programme on Immunisation in 1974. For example, there has been significant progress in introducing new and under-utilised vaccines; including hepatitis B, Haemophilus influenza type b, pneumococcal conjugate, rotavirus, meningococcal A conjugate, and human papillomavirus vaccines. In May 2012, African countries endorsed the Global Vaccine Action Plan at the World Health Assembly. However, more than six million children remain incompletely vaccinated in Africa leading to more than one million vaccine-preventable deaths annually. In addition, there are persistent problems with leadership and planning, vaccine stock management, supply chain capacity and quality, provider-parent communication, and financial sustainability. The conference delegates agreed to move from talking to taking concrete actions around children's health, and to ensure that African governments commit to saving children's lives. They would advocate for lower costs of immunisation programmes in Africa, perhaps through bulk buying and improved administration of vaccine rollout through the New Partnership for Africa's Development.
提高医护人员对疫苗的了解和态度的一种方法是举办疫苗会议,这些会议要方便参与、价格合理且与他们的日常工作相关。全球每年都会举办各种疫苗学会议。这些会议主要聚焦于基础科学,大量讨论疫苗的新进展,而对政策、宣传和沟通问题的涉及相对较少。这些会议中来自非洲的代表比例微乎其微,而非洲承担着全球近40%的疫苗可预防疾病负担。据我们所知,除了世界卫生组织(WHO)的会议外,非洲大陆从未举办过大型疫苗学会议。首届国际非洲疫苗学会议的内容计划有所不同;聚焦于科学,大部分讨论将围绕临床、项目、政策和宣传问题展开。该会议于2012年11月8日至11日在南非开普敦举行。会议主题是“倡导努力保护非洲儿童、家庭和社区免受传染病威胁”。来自55个国家(包括37个非洲国家)的550多名注册参会者参加了会议。会议设有9个会前研讨会、10次全会以及150场口头报告和海报展示。会议讨论了非洲普遍免疫面临的挑战以及促进所有利益相关者就免疫问题开展对话和沟通。大家普遍承认,自1974年全球启动扩大免疫规划以来,非洲已经取得了巨大进步。例如,在引入新的和未充分使用的疫苗方面取得了重大进展;包括乙肝疫苗、b型流感嗜血杆菌疫苗、肺炎球菌结合疫苗、轮状病毒疫苗、A群脑膜炎球菌结合疫苗和人乳头瘤病毒疫苗。2012年5月,非洲国家在世界卫生大会上批准了《全球疫苗行动计划》。然而,非洲仍有超过600万儿童未完成全程接种疫苗,导致每年有超过100万例疫苗可预防死亡。此外,在领导力和规划、疫苗库存管理、供应链能力和质量、医护人员与家长沟通以及财务可持续性方面仍然存在持续性问题。会议代表们一致同意从空谈转向围绕儿童健康采取具体行动,并确保非洲各国政府致力于拯救儿童生命。他们将倡导降低非洲免疫规划的成本,或许可以通过批量采购以及通过非洲发展新伙伴关系改善疫苗推广管理来实现。